Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8668501 | Journal of Clinical Lipidology | 2018 | 9 Pages |
Abstract
Our findings demonstrated that GLP-1RAs reduced the serum LDL-C in Japanese patients with T2DM treated with statins. The percentage reduction in LDL-C by GLP-1RAs was associated with that in HbA1c, but not associated with that in BMI. The combination of GLP-1RAs and statins may be a reasonable therapeutic option in T2DM with dyslipidemia.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Yukiko MD, PhD, Mika PhD, Tomoko MD, PhD, Mariko MD, PhD, Yasuko MD, PhD,